fallopian tube serous adenocarcinoma

Showing 1 - 14 of 14

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +14 more
  • Birmingham, Alabama
  • +399 more
Dec 30, 2022

Fallopian Tube Carcinosarcoma, Fallopian Tube Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial in Buffalo

Not yet recruiting
  • Fallopian Tube Carcinosarcoma
  • +10 more
  • Bevacizumab
  • +4 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Dec 29, 2022

Cervical Adenocarcinoma, Cervical Adenosarcoma, Cervical Adenosquamous Carcinoma Trial in United States (biological, other,

Recruiting
  • Cervical Adenocarcinoma
  • +47 more
  • Bevacizumab
  • +3 more
  • Phoenix, Arizona
  • +3 more
Dec 5, 2022

Ovarian Cancer, Fallopian Tube Adenocarcinoma, Fallopian Tube Carcinosarcoma Trial in Seattle (Exercise Counseling, Aerobic

Terminated
  • Ovarian Cancer
  • +21 more
  • Exercise Counseling
  • +5 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 6, 2022

Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma, Fallopian Tube Serous Adenocarcinoma Trial

Recruiting
  • Fallopian Tube Endometrioid Adenocarcinoma
  • +32 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Sep 16, 2022

Fallopian Tube Serous Adenocarcinoma, High Grade Ovarian Serous Adenocarcinoma, Ovarian Mass Trial in United States (Laboratory

Completed
  • Fallopian Tube Serous Adenocarcinoma
  • +18 more
  • Laboratory Biomarker Analysis
  • BMN 673
  • Houston, Texas
  • +5 more
Feb 11, 2022

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +17 more
  • Phoenix, Arizona
  • +162 more
Sep 28, 2021

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Active, not recruiting
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +26 more
  • Clinical Observation
  • +4 more
  • Birmingham, Alabama
  • +314 more
Sep 28, 2021

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +37 more
  • Bevacizumab
  • +5 more
  • Birmingham, Alabama
  • +502 more
Apr 13, 2021

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +34 more
  • Gilbert, Arizona
  • +6 more
Aug 27, 2019

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +19 more
  • Hartford, Connecticut
  • +13 more
Aug 8, 2019

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Completed
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +26 more
  • Bevacizumab
  • +5 more
  • Anniston, Alabama
  • +631 more
Jul 19, 2019

YKL-40 in Serum Samples From Newly Diagnosed Stage III-IV

Terminated
  • Fallopian Tube Adenocarcinoma
  • +29 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Mobile, Alabama
  • +130 more
May 21, 2018

Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube Mucinous Adenocarcinoma

Unknown status
  • Fallopian Tube Clear Cell Adenocarcinoma
  • +32 more
  • Behavioral Dietary Intervention
  • +7 more
  • Birmingham, Alabama
  • +686 more
Feb 14, 2018